Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Beginners can start with a clear, low-risk entry into crypto. This intro explains selecting a primary asset, setting investment caps, and gradually expanding.
19,656 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The latest Shake Shack earnings sparked a notable stock rally. This article breaks down the factors driving the move,...
Monster Beverage's 2025 earnings outlook centers on international growth, margin improvements, and strategic branding...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
Memory chips are the quiet engine behind AI growth. The shocking 1,290% surge in sandisk stock over the past year sig...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Investing in short-term bonds means choosing between security and income. This guide breaks down SCHO and ISTB, showi...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
On Holding's stock has caught the eye of many long-term investors who pay attention to fundamentals rather than short...
Two small modular reactor players, NuScale Power and Oklo, are reshaping how utilities think about clean energy. This...
When a new Berkshire CEO speaks candidly about returns, investors sit up. This article digs into what 'greg abel call...